Second patent filed for novel orexin 1 antagonist programme

A second patent application for novel orexin 1 antagonists has been filed on 25 October 2017. This is an entirely new composition of matter patent supporting our binge eating disorder and alcohol use disorder programmes.

Contact Us

Want to get in touch? Send us an email.

Not readable? Change text. captcha txt